What disease does Flupentixol and melitracen treat?

summary

The indications of Flupentixol and melitracen tablets were mild to moderate depression and anxiety. Neurasthenia, psychogenic depression, depressive neurosis, occult depression, psychosomatic diseases with anxiety and apathy, menopausal depression, anxiety and depression of alcoholics and drug addicts. What disease does Flupentixol and melitracen treat? Let's talk about it

What disease does Flupentixol and melitracen treat?

Flupentixol melitracen tablets can strengthen the chain reaction of the body to barbital, ethanol and other central nervous system inhibitors. The combination with monoamine oxidase inhibitors may lead to hypertension risk. Antidepressants and nerve blockers can reduce the antihypertensive effect of guanidine and similar compounds. Antidepressants can also enhance the effects of norepinephrine and epinephrine.

Flupentixol - a nerve blocker with anti anxiety and anti depression effects in small doses. Melitracen - a biphasic antidepressant with agitation characteristics at low dose, is suitable for mild to moderate anxiety and depression. The onset time of curative effect is faster than that of common 5-HT reuptake inhibitors. In general, it takes 2-3 days to take effect, and the effect is very significant after one week. Deanxit is a compound preparation made of trifluorothiazide and tetramethylanthracene propylamine.

In general, Flupentixol and melitracen tablets are not sleeping pills. They are mainly used for the treatment of mild and medium-sized anxiety and depression. However, they have good curative effect for insomnia caused by depression. Each patient's specific case is very different, so it should be taken in combination with his own actual situation,

matters needing attention

Medication during pregnancy must be cautious. Since the withdrawal symptoms of newborns can not be ruled out, it is suggested to gradually reduce the dosage of this product within 14 days before the due date of delivery. During treatment, patients with suicidal tendencies should not be given large amounts of drugs. For patients with angle closure glaucoma and shallow anterior chamber, the use of this product will stimulate pupil dilation and lead to acute attack of glaucoma.